 NEW YORK, Oct. 7, 2021 PRNewswire -- Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. Annovis or the Company NYSE: ANVS and certain of its officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 21-cv-04040, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Annovis securities between May 21, 2021 and July 28, 2021, inclusive the Class Period. 